XSHE
300821
, Last price
CNY
Name
Shandong Dongyue Organosilicon Materials Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Shandong Dongyue Organosilicon Materials Co., Ltd. (SDOMS) specializes in the full lifecycle of silicone materials, from their research and development to their production and sale, predominantly serving the Chinese market. The company offers a diverse portfolio of key organosilicon products, which includes silicone monomers, intermediates, fumed silica, silicone rubber, silicone oil, and various other advanced derivatives. These essential materials find critical applications across a multitude of industries, such as military, aerospace, construction, textiles, automotive, machinery, electronic devices, chemical processing, leather and paper manufacturing, and the medical and healthcare sectors. Beyond its strong domestic presence, SDOMS also maintains a significant international reach, exporting its products to numerous countries. Key export markets include Dubai, South Korea, Belgium, the United States, Italy, India, Malaysia, Turkey, and Taiwan, among others globally. Founded in 2006, the company's headquarters are located in Zibo, China. SDOMS operates as a subsidiary of Dongyue Fugui Technology Group Co., Ltd.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||